Cargando…

BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular Targets

Urothelial carcinoma (UC), the sixth most common cancer in Western countries, includes upper tract urothelial carcinoma (UTUC) and bladder carcinoma (BC) as the most common cancers among UCs (90–95%). BC is the most common cancer and can be a highly heterogeneous disease, including both non-muscle-i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Claps, Francesco, Pavan, Nicola, Ongaro, Luca, Tierno, Domenico, Grassi, Gabriele, Trombetta, Carlo, Tulone, Gabriele, Simonato, Alchiede, Bartoletti, Riccardo, Mertens, Laura S., van Rhijn, Bas W. G., Mir, Maria Carmen, Scaggiante, Bruna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454200/ https://www.ncbi.nlm.nih.gov/pubmed/37628785 http://dx.doi.org/10.3390/ijms241612596

Ejemplares similares

The Utility of Inflammatory Serum Markers in the Assessment of Perioperative Morbidity after Radical Cystectomy for Bladder Cancer
por: Claps, Francesco, et al.
Publicado: (2023)

Analysis of Bacterial Stent Colonization: The Role of Urine and Device Microbiological Cultures
por: Tulone, Gabriele, et al.
Publicado: (2023)

A conservative treatment for eosinophilic cystitis
por: Simonato, Franco Alchiede, et al.
Publicado: (2022)

Antibiotic prophylaxis in patients who had undergone to prostate biopsy in between the EMA warning era: effects of fluoroquinolones in diabetic and non-diabetic patients. Results of an observational cohort study
por: Bartoletti, Riccardo, et al.
Publicado: (2022)

Comparison of Fluoroquinolones and Other Antibiotic Prophylaxis Regimens for Preventing Complications in Patients Undergoing Transrectal Prostate Biopsy
por: Tulone, Gabriele, et al.
Publicado: (2022)

Sentinel Lymph Node Biopsy in Prostate Cancer: An Overview of Diagnostic Performance, Oncological Outcomes, Safety, and Feasibility
por: Rossin, Giulio, et al.
Publicado: (2023)

An Overview of Circulating Cell-Free Nucleic Acids in Diagnosis and Prognosis of Triple-Negative Breast Cancer
por: Tierno, Domenico, et al.
Publicado: (2023)

Preliminary Results of ERAS Protocol in a Single Surgeon Prospective Case Series
por: Tulone, Gabriele, et al.
Publicado: (2022)

Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications
por: Tierno, Domenico, et al.
Publicado: (2023)

Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer
por: Kamat, Ashish M., et al.
Publicado: (2017)

An Overview of siRNA Delivery Strategies for Urological Cancers
por: Halib, Nadia, et al.
Publicado: (2022)

Editorial: Telemedicine and telementoring in urology practice
por: Tulone, Gabriele, et al.
Publicado: (2023)

High eEF1A1 Protein Levels Mark Aggressive Prostate Cancers and the In Vitro Targeting of eEF1A1 Reveals the eEF1A1–actin Complex as a New Potential Target for Therapy
por: Bosutti, Alessandra, et al.
Publicado: (2022)

A Case–Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection
por: Bortul, Marina, et al.
Publicado: (2023)

Intravesical ALT-803 for BCG-unresponsive Bladder Cancer – A Case Report
por: Huang, Jeffrey, et al.
Publicado: (2017)

Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients
por: de Jong, Joep J., et al.
Publicado: (2018)

Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors
por: Moreo, Eduardo, et al.
Publicado: (2022)

Role of D-Mannose in the Prevention of Recurrent Uncomplicated Cystitis: State of the Art and Future Perspectives
por: De Nunzio, Cosimo, et al.
Publicado: (2021)

Bacillus Calmette-Guérin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease
por: Steinberg, Ryan L., et al.
Publicado: (2016)

Letter to the Editor: Bacillus Calmette-Guerin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease
por: Li, Roger, et al.
Publicado: (2017)

Efficacy of Mycobacterium Phlei Cell Wall-Nucleic Acid Complex (MCNA) in BCG-Unresponsive Patients
por: Li, Roger, et al.
Publicado: (2017)

Risk of Virus Contamination Through Surgical Smoke During Minimally Invasive Surgery: A Systematic Review of the Literature on a Neglected Issue Revived in the COVID-19 Pandemic Era
por: Pavan, Nicola, et al.
Publicado: (2020)

BCG-unresponsive high-grade non-muscle invasive bladder cancer: what does the practicing urologist need to know?
por: Lebacle, Cedric, et al.
Publicado: (2021)

Reliable Prediction of Post-Operative Complications’ Rate Using the G8 Screening Tool: A Prospective Study on Elderly Patients Undergoing Surgery for Kidney Cancer
por: Traunero, Fabio, et al.
Publicado: (2022)

Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals
por: Bosutti, Alessandra, et al.
Publicado: (2016)

Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches
por: Jesenko, Tanja, et al.
Publicado: (2023)

Bacillus Calmette-Guérin (BCG) Treatment Failures in Non-Muscle Invasive Bladder Cancer: What Truly Constitutes Unresponsive Disease
por: Steinberg, Ryan L., et al.
Publicado: (2015)

Arterioureteral fistula: An unusual cause of haematuria 10 years after the implantation of a synthetic iliac-femoral stent
por: Ongaro, Luca, et al.
Publicado: (2023)

Lingual mucosal graft urethroplasty 12 years later: Systematic review and meta-analysis
por: Abrate, Alberto, et al.
Publicado: (2019)

Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful During and After the COVID-19 Pandemic?
por: Novara, Giacomo, et al.
Publicado: (2020)

Urology practice during the COVID-19 vaccination campaign
por: Ficarra, Vincenzo, et al.
Publicado: (2021)

Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)
por: Cooper, Owen Alan Edwards, et al.
Publicado: (2023)

Intravesical gemcitabine as bladder‐preserving treatment for BCG unresponsive non‐muscle‐invasive bladder cancer. Results from a single‐arm, open‐label study
por: Hurle, Rodolfo, et al.
Publicado: (2020)

Required efficacy for novel therapies in BCG‐unresponsive non‐muscle invasive bladder cancer: Do current recommendations really reflect clinically meaningful outcomes?
por: Wettstein, Marian S., et al.
Publicado: (2020)

Multi-country clinical practice patterns, including use of biomarkers, among physicians’ treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC)
por: Broughton, Edward I., et al.
Publicado: (2022)

Xenograft Zebrafish Models for the Development of Novel Anti-Hepatocellular Carcinoma Molecules
por: Tonon, Federica, et al.
Publicado: (2021)

Transfer of specific unresponsiveness to organ allografts by thymocytes. Specific unresponsiveness by thymocyte transfer
Publicado: (1979)

Methylene blue unresponsive methemoglobinemia
por: Patnaik, Sibabratta, et al.
Publicado: (2014)

Golimumab in unresponsive ulcerative colitis
por: Lippert, Elisabeth, et al.
Publicado: (2014)

Methylene blue unresponsive methemoglobinemia
por: Mirakbari, Seyed Mostafa
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hb9nj312lrt8c3mdsi6ijfjlhl